Issue 17, 2022

PharmaChk: a decade of research and development towards the first quantitative, field-based medicine quality screening instrument

Abstract

Biomedical and clinical scientists play a major role in translating observations into interventions – therapeutics, diagnostics, and medical devices including screening instruments – that improve the health of individuals and the public. This path from observation to intervention is often long and beset with obstacles, many unanticipated. We believe that sharing concrete, real-word examples of scientists in academia moving along this path will highlight some of the types of challenges one may face; here we focus on an intervention being developed by the Zaman lab at Boston University – PharmaChk, the first quantitative, field-based instrument for medicine quality screening. Specifically, this paper describes the first ten years of scientific and engineering work towards the development of this instrument. Launched from a need observed by medicine quality scientists, the development of PharmaChk has required the integration of multiple technologies enabled by knowledge and expertise across diverse fields of science and engineering, including chemistry, ultrasonics, fluid dynamics, optics, computer science, and automation. These efforts have been shaped and driven by the many challenges we have faced and the technical, commercial, and financial support that we have received from many collaborators. By sharing this example, we hope to inspire our colleagues to pursue their own paths to new healthcare solutions.

Graphical abstract: PharmaChk: a decade of research and development towards the first quantitative, field-based medicine quality screening instrument

Article information

Article type
Tutorial Review
Submitted
18 févr. 2022
Accepted
04 mai 2022
First published
13 mai 2022

Analyst, 2022,147, 3805-3816

PharmaChk: a decade of research and development towards the first quantitative, field-based medicine quality screening instrument

A. J. Acevedo, D. Desai, M. H. Zaman and G. Apiou-Sbirlea, Analyst, 2022, 147, 3805 DOI: 10.1039/D2AN00284A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements